カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のヒトマイクロバイオームシーケンス機器市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Human Microbiome Sequencing Instrument Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22MY7966）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22MY7966
■ 発行日：2022年5月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：123
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のヒトマイクロバイオームシーケンス機器市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ヒトマイクロバイオームシーケンス機器市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のヒトマイクロバイオームシーケンス機器の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ヒトマイクロバイオームシーケンス機器市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・試薬＆キット、機器、液体処理機器、サイトメーター、イメージングデバイス、マイクロプレートリーダー、その他

用途別セグメントは次のように区分されます。
・研究機関＆学術機関、製薬＆バイオテクノロジー企業、病院＆診療所、その他

世界のヒトマイクロバイオームシーケンス機器市場の主要な市場プレーヤーは以下のとおりです。
・Baseclear B.V.、Beijing Genomics Institute (BGI) Genomics Co., Ltd、Charles River Laboratories International Inc.、Clinical Microbiomics A/S、Eurofins Scientific SE、GENEWIZ, Inc.、Illumina, Inc.、Novogene Corporation、OraSure Technologies, Inc.、Oxford Nanopore Technologies, Inc.、Pacific Biosciences of California, Inc.、QIAGEN N.V.、Second Genome, Inc.、Thermo Fisher Scientific Inc.、Viome, Inc.、CosmosID、Leucine Rich Bio Pvt. Ltd.、Microba、Microbiome Insights Inc.、Molzym GmbH & Co. KG

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒトマイクロバイオームシーケンス機器製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒトマイクロバイオームシーケンス機器メーカーの企業概要、2019年～2022年までのヒトマイクロバイオームシーケンス機器の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒトマイクロバイオームシーケンス機器メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ヒトマイクロバイオームシーケンス機器の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのヒトマイクロバイオームシーケンス機器の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒトマイクロバイオームシーケンス機器市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヒトマイクロバイオームシーケンス機器の産業チェーンを掲載しています。
・第13、14、15章では、ヒトマイクロバイオームシーケンス機器の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Baseclear B.V.、Beijing Genomics Institute (BGI) Genomics Co., Ltd、Charles River Laboratories International Inc.、Clinical Microbiomics A/S、Eurofins Scientific SE、GENEWIZ, Inc.、Illumina, Inc.、Novogene Corporation、OraSure Technologies, Inc.、Oxford Nanopore Technologies, Inc.、Pacific Biosciences of California, Inc.、QIAGEN N.V.、Second Genome, Inc.、Thermo Fisher Scientific Inc.、Viome, Inc.、CosmosID、Leucine Rich Bio Pvt. Ltd.、Microba、Microbiome Insights Inc.、Molzym GmbH & Co. KG
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：試薬＆キット、機器、液体処理機器、サイトメーター、イメージングデバイス、マイクロプレートリーダー、その他
・用途別分析2017年-2028年：研究機関＆学術機関、製薬＆バイオテクノロジー企業、病院＆診療所、その他
・ヒトマイクロバイオームシーケンス機器の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ヒトマイクロバイオームシーケンス機器のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ヒトマイクロバイオームシーケンス機器のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ヒトマイクロバイオームシーケンス機器の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ヒトマイクロバイオームシーケンス機器の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Human Microbiome Sequencing Instrument market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Microbiome Sequencing Instrument market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Research and Academic Institutions accounting for % of the Human Microbiome Sequencing Instrument global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Reagents and Kits segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Microbiome Sequencing Instrument include Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S, and Eurofins Scientific SE, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Microbiome Sequencing Instrument market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Reagents and Kits
Instruments
Liquid Handling Instruments
Cytometers
Imaging Devices
Microplate Reader
Others
Market segment by Application can be divided into
Research and Academic Institutions
Pharmaceutical and Biotechnology Companies
Hospital and Clinic
Others
The key market players for global Human Microbiome Sequencing Instrument market are listed below:
Baseclear B.V.
Beijing Genomics Institute (BGI) Genomics Co., Ltd
Charles River Laboratories International Inc.
Clinical Microbiomics A/S
Eurofins Scientific SE
GENEWIZ, Inc.
Illumina, Inc.
Novogene Corporation
OraSure Technologies, Inc.
Oxford Nanopore Technologies, Inc.
Pacific Biosciences of California, Inc.
QIAGEN N.V.
Second Genome, Inc.
Thermo Fisher Scientific Inc.
Viome, Inc.
CosmosID
Leucine Rich Bio Pvt. Ltd.
Microba
Microbiome Insights Inc.
Molzym GmbH & Co. KG
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Microbiome Sequencing Instrument product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Microbiome Sequencing Instrument, with price, sales, revenue and global market share of Human Microbiome Sequencing Instrument from 2019 to 2022.
Chapter 3, the Human Microbiome Sequencing Instrument competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Microbiome Sequencing Instrument breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Microbiome Sequencing Instrument market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Microbiome Sequencing Instrument.
Chapter 13, 14, and 15, to describe Human Microbiome Sequencing Instrument sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Human Microbiome Sequencing Instrument Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Microbiome Sequencing Instrument Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Reagents and Kits
1.2.3 Instruments
1.2.4 Liquid Handling Instruments
1.2.5 Cytometers
1.2.6 Imaging Devices
1.2.7 Microplate Reader
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Microbiome Sequencing Instrument Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Research and Academic Institutions
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Hospital and Clinic
1.3.5 Others
1.4 Global Human Microbiome Sequencing Instrument Market Size & Forecast
1.4.1 Global Human Microbiome Sequencing Instrument Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Microbiome Sequencing Instrument Sales in Volume (2017-2028)
1.4.3 Global Human Microbiome Sequencing Instrument Price (2017-2028)
1.5 Global Human Microbiome Sequencing Instrument Production Capacity Analysis
1.5.1 Global Human Microbiome Sequencing Instrument Total Production Capacity (2017-2028)
1.5.2 Global Human Microbiome Sequencing Instrument Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Microbiome Sequencing Instrument Market Drivers
1.6.2 Human Microbiome Sequencing Instrument Market Restraints
1.6.3 Human Microbiome Sequencing Instrument Trends Analysis
2 Manufacturers Profiles
2.1 Baseclear B.V.
2.1.1 Baseclear B.V. Details
2.1.2 Baseclear B.V. Major Business
2.1.3 Baseclear B.V. Human Microbiome Sequencing Instrument Product and Services
2.1.4 Baseclear B.V. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd
2.2.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Details
2.2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Major Business
2.2.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Instrument Product and Services
2.2.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Charles River Laboratories International Inc.
2.3.1 Charles River Laboratories International Inc. Details
2.3.2 Charles River Laboratories International Inc. Major Business
2.3.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Instrument Product and Services
2.3.4 Charles River Laboratories International Inc. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Clinical Microbiomics A/S
2.4.1 Clinical Microbiomics A/S Details
2.4.2 Clinical Microbiomics A/S Major Business
2.4.3 Clinical Microbiomics A/S Human Microbiome Sequencing Instrument Product and Services
2.4.4 Clinical Microbiomics A/S Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Eurofins Scientific SE
2.5.1 Eurofins Scientific SE Details
2.5.2 Eurofins Scientific SE Major Business
2.5.3 Eurofins Scientific SE Human Microbiome Sequencing Instrument Product and Services
2.5.4 Eurofins Scientific SE Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GENEWIZ, Inc.
2.6.1 GENEWIZ, Inc. Details
2.6.2 GENEWIZ, Inc. Major Business
2.6.3 GENEWIZ, Inc. Human Microbiome Sequencing Instrument Product and Services
2.6.4 GENEWIZ, Inc. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Illumina, Inc.
2.7.1 Illumina, Inc. Details
2.7.2 Illumina, Inc. Major Business
2.7.3 Illumina, Inc. Human Microbiome Sequencing Instrument Product and Services
2.7.4 Illumina, Inc. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novogene Corporation
2.8.1 Novogene Corporation Details
2.8.2 Novogene Corporation Major Business
2.8.3 Novogene Corporation Human Microbiome Sequencing Instrument Product and Services
2.8.4 Novogene Corporation Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 OraSure Technologies, Inc.
2.9.1 OraSure Technologies, Inc. Details
2.9.2 OraSure Technologies, Inc. Major Business
2.9.3 OraSure Technologies, Inc. Human Microbiome Sequencing Instrument Product and Services
2.9.4 OraSure Technologies, Inc. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Oxford Nanopore Technologies, Inc.
2.10.1 Oxford Nanopore Technologies, Inc. Details
2.10.2 Oxford Nanopore Technologies, Inc. Major Business
2.10.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Instrument Product and Services
2.10.4 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Pacific Biosciences of California, Inc.
2.11.1 Pacific Biosciences of California, Inc. Details
2.11.2 Pacific Biosciences of California, Inc. Major Business
2.11.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Instrument Product and Services
2.11.4 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 QIAGEN N.V.
2.12.1 QIAGEN N.V. Details
2.12.2 QIAGEN N.V. Major Business
2.12.3 QIAGEN N.V. Human Microbiome Sequencing Instrument Product and Services
2.12.4 QIAGEN N.V. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Second Genome, Inc.
2.13.1 Second Genome, Inc. Details
2.13.2 Second Genome, Inc. Major Business
2.13.3 Second Genome, Inc. Human Microbiome Sequencing Instrument Product and Services
2.13.4 Second Genome, Inc. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Thermo Fisher Scientific Inc.
2.14.1 Thermo Fisher Scientific Inc. Details
2.14.2 Thermo Fisher Scientific Inc. Major Business
2.14.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Instrument Product and Services
2.14.4 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Viome, Inc.
2.15.1 Viome, Inc. Details
2.15.2 Viome, Inc. Major Business
2.15.3 Viome, Inc. Human Microbiome Sequencing Instrument Product and Services
2.15.4 Viome, Inc. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 CosmosID
2.16.1 CosmosID Details
2.16.2 CosmosID Major Business
2.16.3 CosmosID Human Microbiome Sequencing Instrument Product and Services
2.16.4 CosmosID Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Leucine Rich Bio Pvt. Ltd.
2.17.1 Leucine Rich Bio Pvt. Ltd. Details
2.17.2 Leucine Rich Bio Pvt. Ltd. Major Business
2.17.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Instrument Product and Services
2.17.4 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Microba
2.18.1 Microba Details
2.18.2 Microba Major Business
2.18.3 Microba Human Microbiome Sequencing Instrument Product and Services
2.18.4 Microba Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Microbiome Insights Inc.
2.19.1 Microbiome Insights Inc. Details
2.19.2 Microbiome Insights Inc. Major Business
2.19.3 Microbiome Insights Inc. Human Microbiome Sequencing Instrument Product and Services
2.19.4 Microbiome Insights Inc. Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Molzym GmbH & Co. KG
2.20.1 Molzym GmbH & Co. KG Details
2.20.2 Molzym GmbH & Co. KG Major Business
2.20.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Instrument Product and Services
2.20.4 Molzym GmbH & Co. KG Human Microbiome Sequencing Instrument Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Microbiome Sequencing Instrument Breakdown Data by Manufacturer
3.1 Global Human Microbiome Sequencing Instrument Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Microbiome Sequencing Instrument Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Microbiome Sequencing Instrument
3.4 Market Concentration Rate
3.4.1 Top 3 Human Microbiome Sequencing Instrument Manufacturer Market Share in 2021
3.4.2 Top 6 Human Microbiome Sequencing Instrument Manufacturer Market Share in 2021
3.5 Global Human Microbiome Sequencing Instrument Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Microbiome Sequencing Instrument Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Microbiome Sequencing Instrument Market Size by Region
4.1.1 Global Human Microbiome Sequencing Instrument Sales in Volume by Region (2017-2028)
4.1.2 Global Human Microbiome Sequencing Instrument Revenue by Region (2017-2028)
4.2 North America Human Microbiome Sequencing Instrument Revenue (2017-2028)
4.3 Europe Human Microbiome Sequencing Instrument Revenue (2017-2028)
4.4 Asia-Pacific Human Microbiome Sequencing Instrument Revenue (2017-2028)
4.5 South America Human Microbiome Sequencing Instrument Revenue (2017-2028)
4.6 Middle East and Africa Human Microbiome Sequencing Instrument Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Microbiome Sequencing Instrument Sales in Volume by Type (2017-2028)
5.2 Global Human Microbiome Sequencing Instrument Revenue by Type (2017-2028)
5.3 Global Human Microbiome Sequencing Instrument Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Microbiome Sequencing Instrument Sales in Volume by Application (2017-2028)
6.2 Global Human Microbiome Sequencing Instrument Revenue by Application (2017-2028)
6.3 Global Human Microbiome Sequencing Instrument Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Microbiome Sequencing Instrument Sales by Type (2017-2028)
7.2 North America Human Microbiome Sequencing Instrument Sales by Application (2017-2028)
7.3 North America Human Microbiome Sequencing Instrument Market Size by Country
7.3.1 North America Human Microbiome Sequencing Instrument Sales in Volume by Country (2017-2028)
7.3.2 North America Human Microbiome Sequencing Instrument Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Microbiome Sequencing Instrument Sales by Type (2017-2028)
8.2 Europe Human Microbiome Sequencing Instrument Sales by Application (2017-2028)
8.3 Europe Human Microbiome Sequencing Instrument Market Size by Country
8.3.1 Europe Human Microbiome Sequencing Instrument Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Microbiome Sequencing Instrument Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Microbiome Sequencing Instrument Sales by Type (2017-2028)
9.2 Asia-Pacific Human Microbiome Sequencing Instrument Sales by Application (2017-2028)
9.3 Asia-Pacific Human Microbiome Sequencing Instrument Market Size by Region
9.3.1 Asia-Pacific Human Microbiome Sequencing Instrument Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Microbiome Sequencing Instrument Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Microbiome Sequencing Instrument Sales by Type (2017-2028)
10.2 South America Human Microbiome Sequencing Instrument Sales by Application (2017-2028)
10.3 South America Human Microbiome Sequencing Instrument Market Size by Country
10.3.1 South America Human Microbiome Sequencing Instrument Sales in Volume by Country (2017-2028)
10.3.2 South America Human Microbiome Sequencing Instrument Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Microbiome Sequencing Instrument Sales by Type (2017-2028)
11.2 Middle East & Africa Human Microbiome Sequencing Instrument Sales by Application (2017-2028)
11.3 Middle East & Africa Human Microbiome Sequencing Instrument Market Size by Country
11.3.1 Middle East & Africa Human Microbiome Sequencing Instrument Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Microbiome Sequencing Instrument Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Microbiome Sequencing Instrument and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Microbiome Sequencing Instrument
12.3 Human Microbiome Sequencing Instrument Production Process
12.4 Human Microbiome Sequencing Instrument Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Microbiome Sequencing Instrument Typical Distributors
13.3 Human Microbiome Sequencing Instrument Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のシーケンスバッチリアクター（SBR）活性汚泥プロセス市場2022年：市場規模予測（～2028年）
  • 世界の顕微鏡・次世代シーケンサー用カメラ市場2022年：市場規模予測（～2028年）
  • 世界のヒトロタウイルスワクチン市場2022年：市場規模予測（～2028年）
  • 世界の人間羊水市場2022年：市場規模予測（～2028年）
  • 世界の静脈内ヒト免疫グロブリン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22MY7966 )"世界のヒトマイクロバイオームシーケンス機器市場2022年：市場規模予測（～2028年）" (英文：Global Human Microbiome Sequencing Instrument Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。